Valsartan does not exhibit any partial agonist activity at the AT1 receptor and has much (about 20,000-fold) greater affinity for the AT1 receptor than for the AT2 receptor.
Valsartaanil puudub osaline agonistlik toime AT1 - retseptoritele ja tal on tunduvalt (umbes 20000 korda) suurem afiinsus AT1- retseptorite suhtes kui AT2- retseptorite suhtes.